Product description:– Bevitam is a new-generation antiepileptic medication used for the management of partial-onset seizures. It offers effective seizure control with a favourable tolerability profile, enhancing patient compliance in long-term epilepsy management.
Mechanism of Action:- Brivaracetam binds to synaptic vesicle protein 2A (SV2A) in the brain, which reduces abnormal neuronal excitability and prevents seizure propagation.
Indication:- Reduce seizure frequency,Suitable for patients who require an add-on therapy when monotherapy is insufficient.
Common Side Effects:-
Storage:– Store in a cool and dry place, away from direct sunlight and moisture, store at room temperature 28°C。